Longeveron Company
Longeveron is a biotechnology company developing regenerative medicines for the treatment of life threatening diseases associated with ageing.
(Reupload).png)
(Reupload).png)
(Reupload).png)
Technology:
Regenerative Medicine
Industry:
Cell Therapy
Headquarters:
Miami, Florida, United States
Founded Date:
2014
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
3
Total Funding:
$9M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Grant
Register and Claim Ownership